CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Updated Results of the Phase II Study of Pegylated Liposomal Doxorubicin (PLD), Low Dose Dexamethasone (DEX) and Lenalidomide (LEN) In Patients with Newly Diagnosed (ND) Multiple Myeloma (MM)
Author
Daniel Sullivan
Jennifer Paleveda
+9Â more
Jose-Leonel Ochoa-Bayona
Kara Kosakowski
Kenneth Shain
Melissa Alsina
Mohamad A Hussein
Monique A Hartley
Rachid Baz
Taiga Nishihori
William S. Dalton
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref